Drug Shortage Report for AURO-LOSARTAN
Report ID | 145714 |
Drug Identification Number | 02403323 |
Brand name | AURO-LOSARTAN |
Common or Proper name | LOSARTAN POTASSIUM |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 25.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-09-15 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2023-12-06 |
Shortage status | Resolved |
Updated date | 2023-12-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-09-15 | English | Compare |
v2 | 2021-09-15 | French | Compare |
v3 | 2021-09-16 | English | Compare |
v4 | 2021-10-08 | English | Compare |
v5 | 2021-10-08 | French | Compare |
v6 | 2023-12-06 | English | Compare |
v7 | 2023-12-06 | French | Compare |
v8 | 2023-12-07 | English | Compare |
Showing 1 to 8 of 8